Insider · CIK 0001637054

Hatzis-Schoch Brent

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001637054

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-21	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEE REMARKS	AAward	+250K sh	—	—	250,000
2025-01-30	BDTXBlack Diamond Therapeutics, Inc.A Award	SEE REMARKS	AAward	+75K sh	—	—	83,400
2025-01-30	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEE REMARKS	AAward	+175K sh	—	—	175,000
2024-02-14	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEE REMARKS	AAward	+200K sh	—	—	200,000
2023-02-13	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEE REMARKS	AAward	+200K sh	—	—	200,000
2022-02-15	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEE REMARKS	AAward	+90K sh	—	—	90,000
2021-05-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	12,478
2021-05-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−1,161 sh	$26.11	−$30.3K	11,317
2021-05-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−2,566 sh	$27.90	−$71.6K	8,751
2021-05-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−351 sh	$28.20	−$9,899.744	8,400
2021-05-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	160,474
2021-04-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	12,478
2021-04-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−4,078 sh	$25.00	−$102K	8,400
2021-04-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−180K sh	—	—	164,552
2021-03-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	12,478
2021-03-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−4,078 sh	$26.36	−$107K	8,400
2021-03-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	168,630
2021-02-17	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	SEE REMARKS	AAward	+75K sh	—	—	75,000
2021-02-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	12,478
2021-02-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−3,771 sh	$27.19	−$103K	8,707
2021-02-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−307 sh	$27.66	−$8,492.203	8,400
2021-02-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	172,708
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	12,478
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+7,500 sh	$10.86	+$81.5K	19,978
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−2,048 sh	$29.92	−$61.3K	17,930
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−1,669 sh	$30.50	−$50.9K	16,261
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−147 sh	$31.91	−$4,690.432	16,114
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−103 sh	$32.50	−$3,347.232	16,011
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−100 sh	$34.13	−$3,412.5	15,911
2021-01-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−7,511 sh	$36.00	−$270K	8,400
2021-01-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	176,786
2021-01-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−7,500 sh	—	—	71,251
2020-12-28	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+5,400 sh	$3.20	+$17.3K	8,400
2020-12-28	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−5,400 sh	—	—	180,864
2020-12-14	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	7,078
2020-12-14	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−4,078 sh	$34.95	−$143K	3,000
2020-12-14	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	186,264
2020-11-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	7,078
2020-11-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−1,567 sh	$33.46	−$52.4K	5,511
2020-11-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−2,261 sh	$34.24	−$77.4K	3,250
2020-11-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−250 sh	$35.01	−$8,752.175	3,000
2020-11-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	190,342
2020-10-12	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	7,078
2020-10-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−3,783 sh	$32.61	−$123K	3,295
2020-10-12	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−295 sh	$33.75	−$9,957.46	3,000
2020-10-12	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	−4,078 sh	—	—	194,420
2020-09-14	BDTXBlack Diamond Therapeutics, Inc.M Exercise/Conversion	SEE REMARKS	MExercise/Conversion	+4,078 sh	$3.20	+$13K	7,078
2020-09-14	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−2,685 sh	$30.76	−$82.6K	4,393
2020-09-14	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−1,186 sh	$31.42	−$37.3K	3,207
2020-09-14	BDTXBlack Diamond Therapeutics, Inc.S Sale	SEE REMARKS	SSale	−207 sh	$32.55	−$6,737.829	3,000

Recent filings

Accepted (ET)
Jan 234
Hatzis-Schoch Brent0001637054-26-000002
SEC(opens sec.gov)
Jan 314
Hatzis-Schoch Brent0001415889-25-002486
SEC(opens sec.gov)
Feb 154
Hatzis-Schoch Brent0001415889-24-003969
SEC(opens sec.gov)
Feb 154
Hatzis-Schoch Brent0001104659-23-022383
SEC(opens sec.gov)
Feb 174
Hatzis-Schoch Brent0001415889-22-001518
SEC(opens sec.gov)
May 134
Hatzis-Schoch Brent0001104659-21-065995
SEC(opens sec.gov)
Apr 134
Hatzis-Schoch Brent0000899243-21-015666
SEC(opens sec.gov)
Mar 164
Hatzis-Schoch Brent0000899243-21-011958
SEC(opens sec.gov)
Feb 194
Hatzis-Schoch Brent0000899243-21-007450
SEC(opens sec.gov)
Feb 124
Hatzis-Schoch Brent0000899243-21-006454
SEC(opens sec.gov)

Companies

Address

C/O BLACK DIAMOND THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR

CAMBRIDGE, MA, 02142